Leukocyte Surface Antigen CD47 Market, Global Outlook and Forecast 2023-2030
This report aims to provide a comprehensive presentation of the global market for Leukocyte Surface Antigen CD47, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukocyte Surface Antigen CD47. This report contains market size and forecasts of Leukocyte Surface Antigen CD47 in global, including the following market information:
Global Leukocyte Surface Antigen CD47 Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Leukocyte Surface Antigen CD47 Market Sales, 2018-2023, 2024-2030, (K Pcs)
Global top five Leukocyte Surface Antigen CD47 companies in 2022 (%)
The global Leukocyte Surface Antigen CD47 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
B-6H12 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Leukocyte Surface Antigen CD47 include Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc and Trillium Therapeutics Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Leukocyte Surface Antigen CD47 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leukocyte Surface Antigen CD47 Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Leukocyte Surface Antigen CD47 Market Segment Percentages, by Type, 2022 (%)
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Global Leukocyte Surface Antigen CD47 Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Leukocyte Surface Antigen CD47 Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Global Leukocyte Surface Antigen CD47 Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Pcs)
Global Leukocyte Surface Antigen CD47 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leukocyte Surface Antigen CD47 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Leukocyte Surface Antigen CD47 revenues share in global market, 2022 (%)
Key companies Leukocyte Surface Antigen CD47 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Leukocyte Surface Antigen CD47 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Leukocyte Surface Antigen CD47, market overview.
Chapter 2: Global Leukocyte Surface Antigen CD47 market size in revenue and volume.
Chapter 3: Detailed analysis of Leukocyte Surface Antigen CD47 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Leukocyte Surface Antigen CD47 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Leukocyte Surface Antigen CD47 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
